Cutaneous Crohn's disease treated with infliximab and 4 years of follow up

Australas J Dermatol. 2014 Aug;55(3):e40-3. doi: 10.1111/ajd.12069. Epub 2013 Jun 18.

Abstract

Metastatic Crohn's disease (MCD) is a rare, non-contiguous cutaneous manifestation of Crohn's disease. To date, there have been only four reports in the literature of an effective treatment of this condition with infliximab and there are no long-term follow-up studies on adult MCD patients treated with infliximab. We present a case of MCD treated with infliximab with 4.5 years of follow up.

Keywords: infliximab; metastatic Crohn's disease.

Publication types

  • Case Reports

MeSH terms

  • Crohn Disease / drug therapy*
  • Crohn Disease / pathology
  • Dermatologic Agents / therapeutic use*
  • Disease Progression
  • Female
  • Humans
  • Infliximab / therapeutic use*
  • Middle Aged
  • Recurrence
  • Skin Diseases / drug therapy*
  • Skin Diseases / pathology

Substances

  • Dermatologic Agents
  • Infliximab